Drug discovery, formulation science, natural products, clinical and translational research — supported by the SRL (Control Research Lab) and active collaborations.
SRL — Control Research Lab
The research backbone of the college.
The Control Research Lab is the institutional research wing. It provides instrumented
access to faculty and research scholars across the four departments and supports both
basic and translational pharmaceutical research.
Equipment includes HPLC, UV-Vis and FTIR spectrophotometers, dissolution apparatus,
tablet machinery, in-vitro cell-culture facilities, and a CPCSEA-registered animal
house. M.Pharm scholars run thesis work here under faculty supervision.
Research facilities
Instrumentation & labs.
Core instrumentation and facilities available to faculty and research scholars through the Control Research Lab.
High-Performance Liquid Chromatography (HPLC)
Quantitative assay, impurity profiling and method development for drugs and formulations.
Analytical instrumentation
UV–Visible Spectrophotometer
Spectroscopic estimation, assay and dissolution studies.
Analytical instrumentation
FT-IR Spectrophotometer
Functional-group identification and drug–excipient compatibility studies.
Analytical instrumentation
Gas Chromatography (GC)
Separation and estimation of volatile compounds and residual solvents.
Analytical instrumentation
Dissolution Test Apparatus
In-vitro drug-release profiling of solid oral dosage forms.
Formulation & evaluation
Tablet & Capsule Manufacturing Unit
Compression, coating and evaluation of tablet and capsule dosage forms.
Formulation & evaluation
In-vitro Cell-Culture Facility
Cytotoxicity and cell-based screening of drug candidates.
Biological research
CPCSEA-registered Animal House
Approved facility for in-vivo pharmacological, toxicity and behavioural studies.
Biological research
Active areas
What our research targets.
Drug discovery & design
Synthesis, structure-activity studies and biological screening for CNS, CVS, anti-inflammatory and oncology targets.
Formulation science
Novel drug delivery — sustained-release, transdermal, mucoadhesive, ocular and targeted systems.
Natural products
Phytochemistry, ethnobotanical surveys and standardization of herbal and polyherbal formulations.
Clinical & translational
Pharmacovigilance, pharmacoepidemiology, ADR reporting and clinical-pharmacy outcome studies through Pharm.D rotations.
Policy
Institute Research Policy.
The college's research policy sets out the framework for research conduct, ethics, funding, intellectual property and support for faculty and scholars.
SIRO — the college's research unit is recognised as a Scientific and Industrial Research Organisation (SIRO) by the Department of Scientific and Industrial Research (DSIR), Ministry of Science and Technology, Government of India.
By the numbers
Output snapshot.
120+Peer-reviewed publications
8Patents filed
12Sponsored projects
25Research scholars
Research outputs
Publications, books & patents.
Faculty and scholars publish across pharmaceutical sciences, clinical pharmacy and drug delivery. Browse the full records below.
Uzma Sireen, Sreekanth Thota, Neha Amreen, Damerakonda Kumara Swamy, Swarnalatha Katherashala, Sreenath Sriram. PROTACs: Next-generation cancer therapeutics revolutionizing targeted treatment strategies. Insilico Research in Biomedicine, 2, 100386, 2026.
Rashmitha Vallala, Bhaskar Daravath. Niosomes in drug delivery: A comprehensive review and therapeutic perspectives. Next Nanotechnology, 9, 100440, 2026.
Lavanya g. Makarandh a., venkateshwarlu e., sharavana bhava b. S. Sathyanarayana k. A comparative study to assess the safety and efficacy of some oral triple therapy regimens in patients with uncontrolled type 2 diabetes mellitus. International Journal of Pharmacy and Pharmaceutical Sciences, 17(1), 2025.
S. Prathibha, T. Sreeja1 C. Mamata, E. Venkateshwarlu, B.S. Sharvana Bhava, V. Sneha Priya, G. Lavanya, Safiya Naseer, A. Kottai Muthu. Efficacy and Safety of Anti-Hypertensive Drugs in Cardiovascular Diseases. Journal For Basic Sciences. 25 (5), 269-286, 2025.
